Stay updated on Sitravatinib and Tislelizumab in Uveal Melanoma Clinical Trial

Sign up to get notified when there's something new on the Sitravatinib and Tislelizumab in Uveal Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sitravatinib and Tislelizumab in Uveal Melanoma Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    The page's revision level updated from v3.5.3 to v3.5.4, signaling a small internal update to the page. No user-visible content or trial data changes are introduced by this revision.
    Difference
    0.1%
    Check dated 2026-05-15T02:28:51.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Result status on the study page now displays 'Results Submitted' instead of 'No Results Posted'. This updates the study record to show that the trial’s results have been submitted for reporting.
    Difference
    0.1%
    Check dated 2026-05-07T22:00:43.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.5.3, replacing the previous v3.5.2, indicating a minor update to the study record version.
    Difference
    0.1%
    Check dated 2026-04-30T16:43:45.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2 and removed Revision: v3.5.0 from the page.
    Difference
    0.1%
    Check dated 2026-04-16T10:19:16.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    Revision: v3.5.0 was added and Revision: v3.4.3 was removed.
    Difference
    0.1%
    Check dated 2026-03-25T19:02:08.000Z thumbnail image
  8. Check
    85 days ago
    Change Detected
    Summary
    Revision tag updated to v3.4.3, replacing the previous v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-11T14:39:35.000Z thumbnail image

Stay in the know with updates to Sitravatinib and Tislelizumab in Uveal Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sitravatinib and Tislelizumab in Uveal Melanoma Clinical Trial page.